Gabapentin Petition Could Give FDA Opportunity to Revisit Tradeoffs In Opioid Oversight Debate

 
• By Sarah Karlin-Smith
  
DEA logo on wall
Public Citizen Wants FDA and DEA to place gabapentin in schedule V • Source: Alamy

More from Drug Safety

More from Pink Sheet